Tag: Covishield

New Delhi: One of the questions doing the rounds on the COVID-19 vaccination process in India was whether citizens could choose their vaccine from the ones approved by Drugs Controller ...

Pune: The CEO of Serum Institute of India (SII), Adar Poonawalla, on Tuesday said his firm has decided to sell the first 100 million doses of Covishield vaccine at a ...

Pune: The first flight carrying COVID-19 vaccines — Covishield — from the Serum Institute of India (SII) left Pune at 8 am and is expected to land in Delhi at ...

Bhubaneswar: Indigenously developed Covaxin COVID-19 vaccine by Bharat Biotech is likely to be priced lower than Serum Institute's Covishield. Covishield will be sold at Rs 200 per vial to the ...

Mumbai: Serum Institute of India's CEO Adar Poonawalla has revealed the Covishield vaccine prices. The vaccine will be supplied to the government at Rs 250 per dose and will be ...

New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield, manufactured by Pune-based Serum ...

Bhubaneswar: A day after the Drugs Controller General of India (DCGI) formally approved the emergency use of two vaccines in the country, the Odisha government on Monday said that it ...

New Delhi: The new year couldn't have begun on a better note for Pune-based Serum Institute Of India (SII) with Covishield getting the nod for restricted emergency use in India ...

New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from the Drugs Controller ...

New Delhi: The Drug Controller General of India (DCGI) is likely to allow the emergency use of the Covishield vaccine in India without the necessary approval from the UK where ...